Quick Answer
SANUWAVE Health, Inc. reported Total Revenue of $44.05 million for fiscal year 2025.
SANUWAVE Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $44.05M +35.0% |
$32.63M +60.0% |
$20.40M +21.8% |
$16.74M +28.7% |
$13.01M +220.7% |
$4.06M +165.4% |
| Revenue (ASC 606) | — | — | — | — | — | $4.06M +294.4% |
| Net Income | $11.81M +135.7% |
-$33.08M -28.2% |
-$25.81M -150.7% |
-$10.29M +62.2% |
-$27.26M +11.9% |
-$30.94M -196.6% |
| Diluted EPS | $0.41 +105.5% |
-$7.41 +39.2% |
-$12.19 -60850.0% |
-$0.02 +60.0% |
-$0.05 +37.5% |
-$0.08 -60.0% |
| Total Assets | $37.34M +24.0% |
$30.12M +34.4% |
$22.42M +31.8% |
$17.01M -8.6% |
$18.62M -19.1% |
$23.03M +580.9% |
| Cash and Equivalents | $11.96M +16.8% |
$10.24M +469.7% |
$1.80M +474.1% |
$313.0K -49.4% |
$619.0K -74.6% |
$2.44M +38.4% |
| Stockholders Equity | -$20.81M -31.8% |
-$15.79M +64.5% |
-$44.55M -17.0% |
-$38.07M +2.3% |
-$38.96M -184.0% |
-$13.72M -36.3% |
| R&D Expense | $1.35M +101.0% |
$673.0K +16.2% |
$579.0K +2.1% |
$567.0K -48.5% |
$1.10M -11.6% |
$1.25M +5.4% |
| Operating Income | $4.95M +28.5% |
$3.85M +812.6% |
-$540.0K +94.0% |
-$8.95M +36.7% |
-$14.14M +43.9% |
-$25.20M -186.5% |
| Gross Profit | $33.97M +38.4% |
$24.55M +70.9% |
$14.36M +15.7% |
$12.41M +54.7% |
$8.02M +177.2% |
$2.90M +491.0% |
| Shares Outstanding | 8.59M +0.5% |
8.54M +180.9% |
3.04M -99.4% |
548.74M +13.9% |
481.62M +2.3% |
470.69M +60.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $11.45M | +22.3% | +12.7% |
| Revenue (ASC 606) | September 30, 2021 | $3.73M | +172.7% | +28.1% |
| Net Income | September 30, 2025 | $10.32M | +150.0% | +878.7% |
| Diluted EPS | September 30, 2025 | $0.46 | +107.1% | +4500.0% |
| Total Assets | September 30, 2025 | $35.60M | +63.0% | +7.7% |
| Cash and Equivalents | September 30, 2025 | $9.60M | +194.6% | +13.0% |
| Stockholders Equity | September 30, 2025 | -$2.93M | +95.1% | +80.2% |
| R&D Expense | September 30, 2025 | $345.0K | +114.3% | +77.8% |
| Operating Income | September 30, 2025 | $1.47M | -24.9% | -21.8% |
| Gross Profit | September 30, 2025 | $8.93M | +26.3% | +12.2% |
| Shares Outstanding | September 30, 2025 | 8.58M | +172.3% | +0.1% |
- SANUWAVE Health, Inc. reported Total Revenue of $44.05 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +35.0% in Total Revenue compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Revenue (ASC 606) of $4.06 million for fiscal year 2020.
- SANUWAVE Health, Inc. showed an increase of +294.4% in Revenue (ASC 606) compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Net Income of $11.81 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +135.7% in Net Income compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Diluted EPS of $0.41 per share for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +105.5% in Diluted EPS compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Total Assets of $37.34 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +24.0% in Total Assets compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Cash and Equivalents of $11.96 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +16.8% in Cash and Equivalents compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Stockholders Equity of $1.62 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +121.3% in Stockholders Equity compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported R&D Expense of $1.35 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +101.0% in R&D Expense compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Operating Income of $4.95 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +28.5% in Operating Income compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Gross Profit of $33.97 million for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +38.4% in Gross Profit compared to the prior fiscal year.
- SANUWAVE Health, Inc. reported Shares Outstanding of 8.59 million shares for fiscal year 2025.
- SANUWAVE Health, Inc. showed an increase of +0.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: